FDA Inspection 776114 — Shiyao Wu MD
The FDA completed an inspection of Shiyao Wu MD on February 3, 2012 in Shanghai. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 3, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Shanghai (China)
Additional Details
Clinical Investigator (CI)